Skip to content

Evaluation of the effect of injection of bupivacaine by patient into the tooth socket on pain management after surgical extraction of impacted lower third molar

Clinical trial to comparison of bupivacaine(local) and mefnamic acid on mean pain score reported during the first 24 hours after surgical extraction of third molar, in patients with similar bilateral impacted lower third molar.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201204199515N1
Enrollment
48
Registered
2013-01-15
Start date
2012-04-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

impacted teeth. An impacted tooth is a tooth that has failed to erupt because of obstruction by another tooth

Interventions

Intervention 1: Intervention group: Placebo of mefnamic acid 250 mg, every 8 hours during 24 hours following surgery. Intervention 2: Intervention group: Injection of 0.3 cc bupivacaine 0.5% in to th
Placebo
Treatment - Drugs
Intervention group: Placebo of mefnamic acid 250 mg, every 8 hours during 24 hours following surgery.
Intervention group: Injection of 0.3 cc bupivacaine 0.5% in to the tooth socket, every 2 hours during 12 hours following surgery.
Control group: Injection of 0.3cc normal saline in to the tooth socket, every 2 hours during 12 hours following surgery.
Control group: Mefnamic acid 250 mg, every 8 hours during 24 hours following surgery.

Sponsors

Vice chancellor for research, Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Major inclusion criteria: The patients with similar bilateral impacted lower third molar; Patients that have no contraindications for oral surgery; Patients that are able to understand the method of our study. Major exclusion criteria: The length of two surgery of one patient have more than 10 min difference; Not using of drug according to the method that is trained.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Post surgical pain. Timepoint: 24 hours following surgery. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIdeh Talimkhani

Hamadan faculty of dentistry

ideatalimkhani@yahoo.com, i.talimkhani@umsha.ac.ir+98 81 1824 2144

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026